Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Algorithm-guided tacrolimus starting dose in pediatric kidney transplant recipients
NL-OMON44606Recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2017
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus in kidney transplant, sponsored by Erasmus MC. Primary endpoint: Proportion reaching tacrolimus target trough concentration on day 3. Started Nov 2017; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON44606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44606.